2006
DOI: 10.1016/j.jmb.2005.11.018
|View full text |Cite
|
Sign up to set email alerts
|

The Crystal Structure of Human Atg4b, a Processing and De-conjugating Enzyme for Autophagosome-forming Modifiers

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

2
64
0
1

Year Published

2012
2012
2023
2023

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 84 publications
(67 citation statements)
references
References 29 publications
2
64
0
1
Order By: Relevance
“…The AtATG4a putative catalytic triad sequence (C170/D264/H268) is well aligned with the corresponding HsATG4B catalytic triad sequence (C74/D278/H280) (Fig. S8C) 47 suggesting that the processing mechanism of ATG4 homologs might be similar.…”
Section: Yeast and Plant Atg4s Bind Hslc3a But Cannot Process Itmentioning
confidence: 78%
“…The AtATG4a putative catalytic triad sequence (C170/D264/H268) is well aligned with the corresponding HsATG4B catalytic triad sequence (C74/D278/H280) (Fig. S8C) 47 suggesting that the processing mechanism of ATG4 homologs might be similar.…”
Section: Yeast and Plant Atg4s Bind Hslc3a But Cannot Process Itmentioning
confidence: 78%
“…A previously published x-ray crystallography study of the HsAtg4B-LC3 complex showed that Cys-74, Asp-278, and His-280 of HsAtg4B form the catalytic triad (29). The catalytic cleft of HsAtg4B is masked by a regulatory loop (residues 259 to 262) that is lifted by Phe-119 of LC3 (29,30).…”
Section: Atg-41 Is Essential For Degradation Of a Variety Of Autophagymentioning
confidence: 99%
“…The catalytic cleft of HsAtg4B is masked by a regulatory loop (residues 259 to 262) that is lifted by Phe-119 of LC3 (29,30). HsAtg4B recognizes the Phe-119 and Gly-120 residues of LC3 using the regulatory loop and Trp-142, respectively, and this recognition is essential for the processing of LC3 by HsAtg4B (Fig.…”
Section: Atg-41 Is Essential For Degradation Of a Variety Of Autophagymentioning
confidence: 99%
See 1 more Smart Citation
“…Many drugs and compounds that modulate autophagy are currently receiving considerable attention [11,89,108]. These include, for example, autophagy inducers such as the mTORC1 inhibitor rapamycin [109] and its analogues (e.g., CCI-779 [109], RAD001 [110,111], and AP23573 [112]), mTOR kinase inhibitors (e.g., Torin 1 [113], and PP242 [114]), trehalose [115,116], carbamazepine [117], and the newly identified autophagy-inducing peptide Tatbeclin 1 [118]; autophagy inhibitors such as chloroquine [119,120] and hydroxychloroquine [121], Lys05 [122], 3-methyladenine [123] and its derivatives [124], PIK3C3 inhibitors [125], ATG4B inhibitors [126,127], and ATG7 inhibitors [128,129]. Autophagy-modulating drugs that are currently used in clinical trials are summarized in Table 2.…”
Section: Conclusion and Future Prospectsmentioning
confidence: 99%